282
Participants
Start Date
December 31, 2004
Primary Completion Date
October 31, 2005
Study Completion Date
October 31, 2005
Talnetant
talnetant
placebo
Placebo Comparator
risperidone
Active Comparator
GSK Investigational Site, Philadelphia
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Richmond
GSK Investigational Site, Atlanta
GSK Investigational Site, North Miami
GSK Investigational Site, Oak Brook
GSK Investigational Site, St Louis
GSK Investigational Site, Little Rock
GSK Investigational Site, Irving
GSK Investigational Site, Austin
GSK Investigational Site, Pico Rivera
GSK Investigational Site, Cerritos
GSK Investigational Site, Glendale
GSK Investigational Site, Rosemead
GSK Investigational Site, Upland
GSK Investigational Site, National City
GSK Investigational Site, Oceanside
GSK Investigational Site, San Diego
GSK Investigational Site, San Diego
GSK Investigational Site, Anaheim
GSK Investigational Site, Garden Grove
GSK Investigational Site, Clementon
Lead Sponsor
GlaxoSmithKline
INDUSTRY